{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:17:10Z","timestamp":1792610230087,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T00:00:00Z","timestamp":1518134400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1245\/s10434-018-6366-0","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T11:57:00Z","timestamp":1518177420000},"page":"1395-1402","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or Paraganglioma"],"prefix":"10.1245","volume":"25","author":[{"given":"Minerva A.","family":"Romero Arenas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thereasa A.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel M.","family":"Hyde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naifa L.","family":"Busaidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert J.","family":"Cote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimi I.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Gagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W.","family":"Gidley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Kupferman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan K.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven I.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Roland L.","family":"Bassett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Waguespack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy D.","family":"Perrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth G.","family":"Grubbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,9]]},"reference":[{"key":"6366_CR1","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1210\/jc.2005-2178","volume":"91","author":"C Jimenez","year":"2006","unstructured":"Jimenez C, Cote G, Arnold A, Gagel RF. Review: should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes?. J Clin Endocrinol Metab. 2006;91:2851\u201358.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"6366_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/ng.533","volume":"42","author":"Y Qin","year":"2010","unstructured":"Qin Y, Yao L, King EE, et al. Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nat Genet. 2010;42(3):229\u201333.","journal-title":"Nat Genet"},{"key":"6366_CR3","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1126\/science.1175689","volume":"325","author":"HX Hao","year":"2009","unstructured":"Hao HX, Khalimonchuk O, Schraders M, et al. SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science. 2009;325:1139\u201342.","journal-title":"Science"},{"issue":"15","key":"6366_CR4","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1093\/hmg\/ddq206","volume":"19","author":"N Burnichon","year":"2010","unstructured":"Burnichon N, Bri\u00e8re JJ, Lib\u00e9 R, et al. SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet. 2010;19(15):3011\u201320.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"6366_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00439-008-0553-1","volume":"124","author":"IT Yeh","year":"2008","unstructured":"Yeh IT, Lenci RE, Qin Y, et al. A germline mutation of the KIF1B beta gene on 1p36 in a family with neural and nonneural tumors. Hum Genet. 2008;124(3):279\u201385.","journal-title":"Hum Genet"},{"issue":"7","key":"6366_CR6","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/ng.861","volume":"43","author":"I Comino-M\u00e9ndez","year":"2011","unstructured":"Comino-M\u00e9ndez I, Gracia-Azn\u00e1rez FJ, Schiavi F, et al. Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nat Genet. 2011;43(7):663\u201367.","journal-title":"Nat Genet"},{"key":"6366_CR7","unstructured":"Marquard J, Eng C. Multiple Endocrine Neoplasia Type 2. 1999 Sep 27 [Updated 2015 Jun 25]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132017. \n                    https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1257\/\n                    \n                  ."},{"key":"6366_CR8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrendo.2016.185","volume":"13","author":"NGS in PPGL (NGSnPPGL) Study Group, Toledo RA, Burnichon N, Cascon A, et al","year":"2017","unstructured":"NGS in PPGL (NGSnPPGL) Study Group, Toledo RA, Burnichon N, Cascon A, et al. Consensus statement statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas. Nat Rev Endocrinol. 2017;13:233\u201347 \n                    https:\/\/doi.org\/10.1038\/nrendo.2016.185\n                    \n                   Accessed 18 Nov 2016.","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"6366_CR9","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SA Wells","year":"2015","unstructured":"Wells SA, Asa SL, Dralle H, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015;25(6):567\u2013610.","journal-title":"Thyroid"},{"issue":"6","key":"6366_CR10","doi-asserted-by":"publisher","first-page":"R253","DOI":"10.1530\/ERC-11-0170","volume":"18","author":"J Welander","year":"2011","unstructured":"Welander J, S\u00f6derkvist P, Gimm O. Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Endocr Relat Cancer. 2011;18(6):R253\u201376.","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"6366_CR11","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1210\/jc.2009-2830","volume":"95","author":"SG Waguespack","year":"2010","unstructured":"Waguespack SG, Rich T, Grubbs E, Ying AK, Perrier ND, Ayala-Ramirez M, Jimenez C. A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma. J Clin Endocrinol Metab. 2010;95(5):2023\u201337.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"6366_CR12","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0033","volume":"174","author":"PF Plouin","year":"2016","unstructured":"Plouin PF, Amar L, Dekkers OM, et al. Guideline Working Group. European Society of Endocrinology clinical practice guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma. Eur J Endocrinol. 2016;174(5):G1\u201310.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"6366_CR13","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JW Lenders","year":"2014","unstructured":"Lenders JW, Duh QY, Eisenhofer G, et al. Endocrine Society. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915\u201342.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"6366_CR14","doi-asserted-by":"publisher","first-page":"e1288","DOI":"10.1542\/peds.2010-0938","volume":"127","author":"KP Tercyak","year":"2011","unstructured":"Tercyak KP, Hensley Alford S, Emmons KM, Lipkus IM, Wilfond BS, McBride CM. Parents\u2019 attitudes toward pediatric genetic testing for common disease risk. Pediatrics. 2011;127(5):e1288\u201395.","journal-title":"Pediatrics"},{"key":"6366_CR15","first-page":"353","volume":"8","author":"SW Vernon","year":"1999","unstructured":"Vernon SW, Gritz ER, Peterson SK, Perz CA, Marani S, Amos CI, Baile WF. Intention to learn results of genetic testing for hereditary colon cancer. Cancer Epidemiol Biomarkers Prev 1999;8:353\u201360.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"6366_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/978-0-387-70990-1_10","volume-title":"Cross-Cultural Assessment of Psychological Trauma and PTSD","author":"DS Weiss","year":"2007","unstructured":"Weiss, DS. The impact of event scale: revised. In: Wilson JP, Tang CS. editors Cross-cultural assessment of psychological trauma and PTSD. New York: Springer. 2007. p. 219\u201338."},{"issue":"9","key":"6366_CR17","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1080\/08870441003763253","volume":"26","author":"K Wolff","year":"2011","unstructured":"Wolff K, Nordin K, Brun W, Berglund G, Kvale G. Affective and cognitive attitudes, uncertainty avoidance and intention to obtain genetic testing: an extension of the theory of planned behaviour. Psychol Health. 2011;26(9):1143-55.","journal-title":"Psychol Health"},{"key":"6366_CR18","unstructured":"Florida. Supreme Court. Pate v. Threlkel. Wests South Report. 1995;661:278\u201382."},{"key":"6366_CR19","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1089\/gte.2005.9.261","volume":"9","author":"RD Pentz","year":"2005","unstructured":"Pentz RD, Peterson SK, Watts B, Vernon SW, Lynch PM, Koehly LM, Gritz ER. Hereditary nonpolyposis colorectal cancer family members\u2019 perceptions about the duty to inform and health professionals\u2019 role in disseminating genetic information. Genet Test. 2005;9:261\u20138.","journal-title":"Genet Test"},{"key":"6366_CR20","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/jmg.2006.047357","volume":"44","author":"K Kohut","year":"2007","unstructured":"Kohut K, Manno M, Gallinger S, Esplen MJ. Should healthcare providers have a duty to warn family members of individuals with an HNPCC-causing mutation? A survey of patients from the ontario familial colon cancer registry. J Med Genet. 2007;44:404\u20137.","journal-title":"J Med Genet"},{"key":"6366_CR21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10689-007-9117-0","volume":"6","author":"CA Griffin","year":"2007","unstructured":"Griffin CA, Axilbund JE, Codori AM, et al. Patient preferences regarding recontact by cancer genetics clinicians. Fam Cancer. 2007;6:265\u201373.","journal-title":"Fam Cancer"},{"key":"6366_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1023\/B:FAME.0000026838.92085.ec","volume":"3","author":"C Phelps","year":"2004","unstructured":"Phelps C, Platt K, France L, Gray J, Iredale R. Delivering information about cancer genetics via letter to patients at low and moderate risk of familial cancer: a pilot study in Wales. Fam Cancer. 2004;3:55\u20139.","journal-title":"Fam Cancer"},{"issue":"24","key":"6366_CR23","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1001\/jama.1996.03530480027036","volume":"275","author":"C Lerman","year":"1996","unstructured":"Lerman C, Narod S, Schulman K, et al. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA. 1996;275(24):1885\u201392.","journal-title":"JAMA"},{"issue":"8 Pt 1","key":"6366_CR24","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.2105\/AJPH.85.8_Pt_1.1133","volume":"85","author":"H Chaliki","year":"1995","unstructured":"Chaliki H, Loader S, Levenkron JC, Logan-Young W, Hall WJ, Rowley PT. Women\u2019s receptivity to testing for a genetic susceptibility to breast cancer. Am J Public Health. 1995;85(8 Pt 1):1133\u20135.","journal-title":"Am J Public Health"},{"issue":"4","key":"6366_CR25","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1200\/JCO.1994.12.4.843","volume":"12","author":"C Lerman","year":"1994","unstructured":"Lerman C, Daly M, Masny A, Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol. 1994;12(4):843\u201350.","journal-title":"J Clin Oncol"},{"key":"6366_CR26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/ajmg.1320570304","volume":"57","author":"C Lerman","year":"1995","unstructured":"Lerman C, Seay J, Balshem A, Audrain J. Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet. 1995;57:385\u201392.","journal-title":"Am J Med Genet"},{"key":"6366_CR27","unstructured":"Struewing JP1, Lerman C, Kase RG, Giambarresi TR, Tucker MA. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol Biomarkers Prev.1995;4:169\u201373."},{"key":"6366_CR28","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1006\/pmed.1996.0086","volume":"25","author":"MA Andrykowski","year":"1996","unstructured":"Andrykowski MA, Munn RK, Studts JL. Interest in learning of personal genetic risk for cancer: a general population survey. Prev Med. 1996;25:527\u201336.","journal-title":"Prev Med"},{"issue":"1","key":"6366_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/(SICI)1096-8628(19970110)68:1<43::AID-AJMG8>3.0.CO;2-Z","volume":"68","author":"ES Tambor","year":"1997","unstructured":"Tambor ES, Rimer BK, Strigo TS. Genetic testing for breast cancer susceptibility: awareness and interest among women in the general population. Am J Med Genet. 1997;68(1):43\u20139.","journal-title":"Am J Med Genet"},{"issue":"9","key":"6366_CR30","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1136\/jmg.33.9.731","volume":"33","author":"C Julian-Reynier","year":"1996","unstructured":"Julian-Reynier C, Eisinger F, Vennin P, et al. Attitudes towards cancer predictive testing and transmission of information to the family. J Med Genet. 1996;33(9):731\u20136.","journal-title":"J Med Genet"},{"issue":"2","key":"6366_CR31","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/jnci\/89.2.148","volume":"89","author":"C Lerman","year":"1997","unstructured":"Lerman C, Biesecker B, Benkendorf JL, Kerner J, Gomez-Caminero A, Hughes C, Reed MM. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J Natl Cancer Inst. 1997;89(2):148\u201357.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"6366_CR32","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1037\/0022-006X.65.3.414","volume":"65","author":"C Lerman","year":"1997","unstructured":"Lerman C, Schwartz MD, Lin TH, Hughes C, Narod S, Lynch HT. The influence of psychological distress on use of genetic testing for cancer risk. J Consult Clin Psychol. 1997;65(3):414\u201320.","journal-title":"J Consult Clin Psychol"},{"issue":"5","key":"6366_CR33","first-page":"1085","volume":"60","author":"RL Alford","year":"1997","unstructured":"Alford RL, Margolis RL, Ross CA, Richards CS. Screening for 185delAG in the Ashkenazim. Am J Hum Genet. 1997;60(5):1085\u201398.","journal-title":"Am J Hum Genet"},{"issue":"9","key":"6366_CR34","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1200\/JCO.2005.07.102","volume":"23","author":"ER Gritz","year":"2005","unstructured":"Gritz ER, Peterson SK, Vernon SW, et al. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol. 2005;23(9):1902\u201310.","journal-title":"J Clin Oncol"},{"issue":"11","key":"6366_CR35","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1002\/(SICI)1097-0142(19970601)79:11<2219::AID-CNCR21>3.0.CO;2-Y","volume":"79","author":"HT Lynch","year":"1997","unstructured":"Lynch HT, Lemon SJ, Durham C, et al. A descriptive study of BRCA1 testing and reactions to disclosure of test results. Cancer. 1997;79(11):2219\u201328.","journal-title":"Cancer"},{"issue":"2","key":"6366_CR36","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1006\/pmed.1993.1023","volume":"22","author":"RT Croyle","year":"1993","unstructured":"Croyle RT, Lerman C. Interest in genetic testing for colon cancer susceptibility: cognitive and emotional correlates. Prev Med. 1993;22(2):284\u201392.","journal-title":"Prev Med"},{"issue":"1","key":"6366_CR37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1037\/0278-6133.16.1.73","volume":"16","author":"SW Vernon","year":"1997","unstructured":"Vernon SW, Gritz ER, Peterson SK, Amos CI, Perz CA, Baile WF, Lynch PM. Correlates of psychologic distress in colorectal cancer patients undergoing genetic testing for hereditary colon cancer. Health Psychol. 1997;16(1):73\u201386.","journal-title":"Health Psychol"},{"issue":"3","key":"6366_CR38","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1210\/jc.2010-1946","volume":"96","author":"M Ayala-Ramirez","year":"2011","unstructured":"Ayala-Ramirez M, Feng L, Johnson MM, et al. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. J Clin Endocrinol Metab. 2011;96(3):717\u201325.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-018-6366-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-6366-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-6366-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T14:41:56Z","timestamp":1581950516000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-018-6366-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,9]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["6366"],"URL":"https:\/\/doi.org\/10.1245\/s10434-018-6366-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,9]]},"assertion":[{"value":"4 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}